| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_728cbe1f705ae61501f25d61297d180c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2016-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480ca3d5e0193b2fd167fae0f817f59a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_513ead654cb9598c4f5e45103980c8c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88ba5f93fd757c681e1a6b54bdff977c |
| publicationDate |
2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017014371-A1 |
| titleOfInvention |
Sarms and method of use thereof |
| abstract |
This invention is directed to substituted acylanilide compounds and uses thereof in treating muscular dystrophies such as Duchenne muscular dystrophy and Becker muscular dystrophy and in improving or preserving lung function and cardiac function in a subject suffering from Duchenne muscular dystrophy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9969683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010521-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017014370-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10314807-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113811296-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9744149-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10987334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10849873-B2 |
| priorityDate |
2006-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |